Report Detail

Other Global Lung Cancer Diagnostics Market Size, Status and Forecast 2019-2025

  • RnM3453793
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Lung Cancer Diagnostics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Immunoassays
      • 1.4.3 Flow Cytometry
      • 1.4.4 Rapid Tests
      • 1.4.5 Molecular Assays
      • 1.4.6 Tissue Arrays
      • 1.4.7 Circulating Tumor Cells
      • 1.4.8 Pharmacodiagnostics
      • 1.4.9 Biomarkers
      • 1.4.10 Other
    • 1.5 Market by Application
      • 1.5.1 Global Lung Cancer Diagnostics Market Share by Application (2014-2025)
      • 1.5.2 Industrial
      • 1.5.3 Healthcare
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Lung Cancer Diagnostics Market Size
    • 2.2 Lung Cancer Diagnostics Growth Trends by Regions
      • 2.2.1 Lung Cancer Diagnostics Market Size by Regions (2014-2025)
      • 2.2.2 Lung Cancer Diagnostics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Lung Cancer Diagnostics Market Size by Manufacturers
      • 3.1.1 Global Lung Cancer Diagnostics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Lung Cancer Diagnostics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Lung Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Lung Cancer Diagnostics Key Players Head office and Area Served
    • 3.3 Key Players Lung Cancer Diagnostics Product/Solution/Service
    • 3.4 Date of Enter into Lung Cancer Diagnostics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Lung Cancer Diagnostics Market Size by Type (2014-2019)
    • 4.2 Global Lung Cancer Diagnostics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Lung Cancer Diagnostics Market Size (2014-2019)
    • 5.2 Lung Cancer Diagnostics Key Players in United States
    • 5.3 United States Lung Cancer Diagnostics Market Size by Type
    • 5.4 United States Lung Cancer Diagnostics Market Size by Application

    6 Europe

    • 6.1 Europe Lung Cancer Diagnostics Market Size (2014-2019)
    • 6.2 Lung Cancer Diagnostics Key Players in Europe
    • 6.3 Europe Lung Cancer Diagnostics Market Size by Type
    • 6.4 Europe Lung Cancer Diagnostics Market Size by Application

    7 China

    • 7.1 China Lung Cancer Diagnostics Market Size (2014-2019)
    • 7.2 Lung Cancer Diagnostics Key Players in China
    • 7.3 China Lung Cancer Diagnostics Market Size by Type
    • 7.4 China Lung Cancer Diagnostics Market Size by Application

    8 Japan

    • 8.1 Japan Lung Cancer Diagnostics Market Size (2014-2019)
    • 8.2 Lung Cancer Diagnostics Key Players in Japan
    • 8.3 Japan Lung Cancer Diagnostics Market Size by Type
    • 8.4 Japan Lung Cancer Diagnostics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Lung Cancer Diagnostics Market Size (2014-2019)
    • 9.2 Lung Cancer Diagnostics Key Players in Southeast Asia
    • 9.3 Southeast Asia Lung Cancer Diagnostics Market Size by Type
    • 9.4 Southeast Asia Lung Cancer Diagnostics Market Size by Application

    10 India

    • 10.1 India Lung Cancer Diagnostics Market Size (2014-2019)
    • 10.2 Lung Cancer Diagnostics Key Players in India
    • 10.3 India Lung Cancer Diagnostics Market Size by Type
    • 10.4 India Lung Cancer Diagnostics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Lung Cancer Diagnostics Market Size (2014-2019)
    • 11.2 Lung Cancer Diagnostics Key Players in Central & South America
    • 11.3 Central & South America Lung Cancer Diagnostics Market Size by Type
    • 11.4 Central & South America Lung Cancer Diagnostics Market Size by Application

    12 International Players Profiles

    • 12.1 Roche Diagnostics
      • 12.1.1 Roche Diagnostics Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Lung Cancer Diagnostics Introduction
      • 12.1.4 Roche Diagnostics Revenue in Lung Cancer Diagnostics Business (2014-2019)
      • 12.1.5 Roche Diagnostics Recent Development
    • 12.2 BioMérieux
      • 12.2.1 BioMérieux Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Lung Cancer Diagnostics Introduction
      • 12.2.4 BioMérieux Revenue in Lung Cancer Diagnostics Business (2014-2019)
      • 12.2.5 BioMérieux Recent Development
    • 12.3 Qiagen
      • 12.3.1 Qiagen Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Lung Cancer Diagnostics Introduction
      • 12.3.4 Qiagen Revenue in Lung Cancer Diagnostics Business (2014-2019)
      • 12.3.5 Qiagen Recent Development
    • 12.4 Advpharma
      • 12.4.1 Advpharma Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Lung Cancer Diagnostics Introduction
      • 12.4.4 Advpharma Revenue in Lung Cancer Diagnostics Business (2014-2019)
      • 12.4.5 Advpharma Recent Development
    • 12.5 AIT Austrian Institute of Technology
      • 12.5.1 AIT Austrian Institute of Technology Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Lung Cancer Diagnostics Introduction
      • 12.5.4 AIT Austrian Institute of Technology Revenue in Lung Cancer Diagnostics Business (2014-2019)
      • 12.5.5 AIT Austrian Institute of Technology Recent Development
    • 12.6 Courtagen Life Sciences
      • 12.6.1 Courtagen Life Sciences Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Lung Cancer Diagnostics Introduction
      • 12.6.4 Courtagen Life Sciences Revenue in Lung Cancer Diagnostics Business (2014-2019)
      • 12.6.5 Courtagen Life Sciences Recent Development
    • 12.7 DiagnoCure
      • 12.7.1 DiagnoCure Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Lung Cancer Diagnostics Introduction
      • 12.7.4 DiagnoCure Revenue in Lung Cancer Diagnostics Business (2014-2019)
      • 12.7.5 DiagnoCure Recent Development
    • 12.8 BioMark Diagnostics
      • 12.8.1 BioMark Diagnostics Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Lung Cancer Diagnostics Introduction
      • 12.8.4 BioMark Diagnostics Revenue in Lung Cancer Diagnostics Business (2014-2019)
      • 12.8.5 BioMark Diagnostics Recent Development
    • 12.9 Mayo Clinic
      • 12.9.1 Mayo Clinic Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Lung Cancer Diagnostics Introduction
      • 12.9.4 Mayo Clinic Revenue in Lung Cancer Diagnostics Business (2014-2019)
      • 12.9.5 Mayo Clinic Recent Development
    • 12.10 HalioDx SAS
      • 12.10.1 HalioDx SAS Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Lung Cancer Diagnostics Introduction
      • 12.10.4 HalioDx SAS Revenue in Lung Cancer Diagnostics Business (2014-2019)
      • 12.10.5 HalioDx SAS Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.
      As people's awareness of cancer increases and technology advances, as well as private and government support, these are some of the factors that are expected to drive market growth.
      In 2018, the global Lung Cancer Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Lung Cancer Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lung Cancer Diagnostics development in United States, Europe and China.

      The key players covered in this study
      Roche Diagnostics
      BioMérieux
      Qiagen
      Advpharma
      AIT Austrian Institute of Technology
      Courtagen Life Sciences
      DiagnoCure
      BioMark Diagnostics
      Mayo Clinic
      HalioDx SAS

      Market segment by Type, the product can be split into
      Immunoassays
      Flow Cytometry
      Rapid Tests
      Molecular Assays
      Tissue Arrays
      Circulating Tumor Cells
      Pharmacodiagnostics
      Biomarkers
      Other

      Market segment by Application, split into
      Industrial
      Healthcare
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Lung Cancer Diagnostics status, future forecast, growth opportunity, key market and key players.
      To present the Lung Cancer Diagnostics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Lung Cancer Diagnostics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Lung Cancer Diagnostics. Industry analysis & Market Report on Lung Cancer Diagnostics is a syndicated market report, published as Global Lung Cancer Diagnostics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Lung Cancer Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,052.87
      4,579.30
      6,105.73
      3,531.07
      5,296.61
      7,062.14
      424,164.00
      636,246.00
      848,328.00
      278,733.39
      418,100.09
      557,466.78
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report